FDW
KYTX icon

Fourth Dimension Wealth’s Kyverna Therapeutics KYTX Stock Holding History

Fourth Dimension Wealth’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23K Hold
250
– – ﹤0.01% 606
2026
Q1 		$2.16K Hold
250
– – ﹤0.01% 527
2025
Q4 		$2.35K Hold
250
– – ﹤0.01% 533
2025
Q3 		$1.5K Hold
250
– – ﹤0.01% 535
2025
Q2 		$768 Hold
250
– – ﹤0.01% 559
2025
Q1 		$483 Hold
250
– – ﹤0.01% 586
2024
Q4 		$935 Buy
+250
New +$1.2K ﹤0.01% 576

Other funds holding KYTX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Fourth Dimension Wealth's KYTX Position: Q2 2026 in Review

Fourth Dimension Wealth held its Kyverna Therapeutics (KYTX) position steady in Q2 2026 at 250 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Fourth Dimension Wealth first reported a position in KYTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.35K in Q4 2025. 21 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Fourth Dimension Wealth held 250 shares of Kyverna Therapeutics worth $2.23K as of Q2 2026.
  • Fourth Dimension Wealth left its Kyverna Therapeutics share count unchanged in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Fourth Dimension Wealth's portfolio in Q2 2026, its #606 holding.
  • Fourth Dimension Wealth first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Fourth Dimension Wealth's Kyverna Therapeutics position peaked at $2.35K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.